These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23989916)

  • 21. Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study.
    Montes de Oca M; Lopez Varela MV; Jardim J; Stirvulov R; Surmont F
    Pulm Pharmacol Ther; 2016 Jun; 38():10-6. PubMed ID: 27113029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
    Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
    PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting exacerbations in COPD in the Danish general population.
    Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.
    Ichinose M; Takizawa A; Izumoto T; Tadayasu Y; Hamilton AL; Kunz C; Fukuchi Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1673-83. PubMed ID: 26316741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.
    Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Lange P
    Am J Respir Crit Care Med; 2020 Jul; 202(2):210-218. PubMed ID: 32289231
    [No Abstract]   [Full Text] [Related]  

  • 29. Physical activity in COPD patients decreases short-acting bronchodilator use and the number of exacerbations.
    Katajisto M; Koskela J; Lindqvist A; Kilpeläinen M; Laitinen T
    Respir Med; 2015 Oct; 109(10):1320-5. PubMed ID: 26298024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept.
    Leuppi JD; Tandjung R; Anderson SD; Stolz D; Brutsche MH; Bingisser R; Perruchoud AP; Surber C; Knoblauch A; Andersson M; Greiff L; Chan HK; Tamm M
    Pulm Pharmacol Ther; 2005; 18(2):83-8. PubMed ID: 15649849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
    Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin use and respiratory outcomes in asthma-COPD overlap.
    Wu TD; Fawzy A; Kinney GL; Bon J; Neupane M; Tejwani V; Hansel NN; Wise RA; Putcha N; McCormack MC
    Respir Res; 2021 Feb; 22(1):70. PubMed ID: 33637087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and integrated management of COPD.
    Bettoncelli G; Blasi F; Brusasco V; Centanni S; Corrado A; De Benedetto F; De Michele F; Di Maria GU; Donner CF; Falcone F; Mereu C; Nardini S; Pasqua F; Polverino M; Rossi A; Sanguinetti CM
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 May; 31 Suppl 1():3-21. PubMed ID: 24820963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.